Algocyte

About:

Algocyte offers an end-to-end medically-driven solution for remote blood testing and health monitoring.

Website: https://www.algocyte.uk/

Top Investors: SFC Capital

Description:

Algocyte offers an end-to-end medically-driven solution for remote blood testing and health monitoring. Algocyte enables medical professionals to remotely monitor their patients suffering from conditions such as leukemia and other types of cancer, as well as anemia, infection or inflammation, autoimmune, and other blood cell disorders. Algocyte is a medical device that can perform a variety of hematological and biochemical tests. Algocyte generates a more precise profile of an individual's health using all of the data collected than is possible using single snapshots, as is commonly done.

Total Funding Amount:

5.12M GBP

Headquarters Location:

Reading, Reading, United Kingdom

Founded Date:

2019-01-01

Contact Email:

algocyteweb(AT)immunealgorithmics.com

Founders:

Hector Zenil

Number of Employees:

11-50

Last Funding Date:

2021-03-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai